Read the new collection in Materials Advances
We are delighted to introduce our new Materials Advances themed collection focusing on Nanoengineered Biomaterials for Anticancer and Antimicrobial Drug Targeting!
Guest Edited by Sabya Sachi Das (University of North Carolina, USA), Janne Ruokolainen (Aalto University, Finland) and Kavindra Kumar Kesari (Aalto University, Finland)
This collection shines a spotlight on new research covering nanoengineered biomaterials targeting cancer and microbial infections theranostics. Particularly focusing on new research exploring the enhanced physicochemical and biological properties of nanoengineered biomaterials, which has led to their increasingly widespread use for diverse biomedical applications.
All papers are open access and free to read. A selection of the papers are featured below:
Synthesis strategies and cancer therapy applications of PEDOT nanoparticles
Diogo Dias, Leonor Resina, Frederico Castelo Ferreira, Paola Sanjuan-Alberte and Teresa Esteves
Mater. Adv., 2024, 5, 7561-7583
DOI: 10.1039/D4MA00260A
Spike trains in PANI-proteinoid nanomaterials with different light pulse rates
Panagiotis Mougkogiannis and Andrew Adamatzky
Mater. Adv., 2024, 5, 6185-6195
DOI: 10.1039/D4MA00253A
A graphene oxide-based sequential nanocatalyst for efficient tumor combination therapy
Zhenlu Yang, Ying Zhao, Zi Xu, Rongpin Wang and Qing Wang
Mater. Adv., 2024, 5, 5482-5493
DOI: 10.1039/D4MA00109E
We hope you enjoy reading this themed collection!
Did you know?
At Materials Advances, our themed collections are built by collaboration between our Guest Editors and expert Associate Editors. Our Guest Editors guide the scope and curate the contributions in our collections, but all submissions are handled through peer review by our team of resident Associate Editors. This means that as an author you receive a consistent experience, and as a reader you can trust the quality of the science being presented.
If you have an idea for a topical collection in your research field, we’d love to hear from you! Get in touch.
